Trial intelligence / Profile preview

Cyclosporin A vs Mycophenolate Mofetil in PBC-AIH Overlap Syndrome

NCT04376528Phase 4Unknown

Sponsor
West China Hospital of Sichuan University
Start
Jun 2021
Primary completion
Dec 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (AIH-PBC), sponsored by West China Hospital of Sichuan University. Status: unknown.

02

Drugs

cyclosporine
03

Conditions

Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (AIH-PBC)

Beyond the preview

Go deeper on NCT04376528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04376528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call